2022 Q1 Form 10-Q Financial Statement
#000149315222013986 Filed on May 16, 2022
Income Statement
Concept | 2022 Q1 | 2021 Q1 |
---|---|---|
Revenue | $300.00 | $300.00 |
YoY Change | 0.0% | -96.31% |
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $275.0K | $90.69K |
YoY Change | 203.26% | -6.4% |
% of Gross Profit | ||
Research & Development | $1.720K | |
YoY Change | -18.1% | |
% of Gross Profit | ||
Depreciation & Amortization | $0.00 | $0.00 |
YoY Change | -100.0% | |
% of Gross Profit | ||
Operating Expenses | $0.00 | $93.56K |
YoY Change | -100.0% | -28.33% |
Operating Profit | -$275.9K | |
YoY Change | ||
Interest Expense | -$8.920K | -$5.170K |
YoY Change | 72.53% | |
% of Operating Profit | ||
Other Income/Expense, Net | -$27.01K | |
YoY Change | ||
Pretax Income | -$302.9K | -$102.7K |
YoY Change | 195.1% | -16.14% |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$302.9K | -$102.7K |
YoY Change | 195.09% | -16.13% |
Net Earnings / Revenue | -100973.67% | -34217.67% |
Basic Earnings Per Share | $0.00 | |
Diluted Earnings Per Share | -$3.500K | -$1.358K |
COMMON SHARES | ||
Basic Shares Outstanding | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2022 Q1 | 2021 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $52.62K | $31.88K |
YoY Change | 65.06% | 27.67% |
Cash & Equivalents | $52.62K | |
Short-Term Investments | ||
Other Short-Term Assets | $138.8K | $700.00 |
YoY Change | 19725.71% | |
Inventory | ||
Prepaid Expenses | ||
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $191.4K | $32.58K |
YoY Change | 487.48% | -50.08% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $109.9K | $0.00 |
YoY Change | -100.0% | |
TOTAL ASSETS | ||
Total Short-Term Assets | $191.4K | $32.58K |
Total Long-Term Assets | $109.9K | $0.00 |
Total Assets | $301.3K | $32.58K |
YoY Change | 824.77% | -93.2% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $80.05K | $91.75K |
YoY Change | -12.75% | 113.57% |
Accrued Expenses | $32.84K | $10.70K |
YoY Change | 206.92% | |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $220.0K | $185.0K |
YoY Change | 18.92% | 146.67% |
Long-Term Debt Due | $1.390K | |
YoY Change | ||
Total Short-Term Liabilities | $661.0K | $287.4K |
YoY Change | 129.94% | 127.59% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $107.5K | $35.60K |
YoY Change | 201.85% | |
Other Long-Term Liabilities | $163.3K | |
YoY Change | ||
Total Long-Term Liabilities | $270.8K | $35.60K |
YoY Change | 660.65% | |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $661.0K | $287.4K |
Total Long-Term Liabilities | $270.8K | $35.60K |
Total Liabilities | $931.7K | $323.0K |
YoY Change | 188.43% | 155.77% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | ||
YoY Change | ||
Common Stock | ||
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$630.5K | -$290.5K |
YoY Change | ||
Total Liabilities & Shareholders Equity | $301.3K | $32.58K |
YoY Change | 824.77% | -93.2% |
Cashflow Statement
Concept | 2022 Q1 | 2021 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$302.9K | -$102.7K |
YoY Change | 195.09% | -16.13% |
Depreciation, Depletion And Amortization | $0.00 | $0.00 |
YoY Change | -100.0% | |
Cash From Operating Activities | -$88.59K | -$107.9K |
YoY Change | -17.87% | -3.99% |
INVESTING ACTIVITIES | ||
Capital Expenditures | -$109.9K | |
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | -$109.9K | |
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 196.8K | 113.0K |
YoY Change | 74.16% | -17.32% |
NET CHANGE | ||
Cash From Operating Activities | -88.59K | -107.9K |
Cash From Investing Activities | -109.9K | |
Cash From Financing Activities | 196.8K | 113.0K |
Net Change In Cash | -1.680K | $0.00 |
YoY Change | -100.0% | |
FREE CASH FLOW | ||
Cash From Operating Activities | -$88.59K | -$107.9K |
Capital Expenditures | -$109.9K | |
Free Cash Flow | $21.30K | |
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q4 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
USD | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
USD | |
CY2021Q4 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
USD | |
CY2021Q4 | CLOQ |
Common Stock Settlement Liability Current
CommonStockSettlementLiabilityCurrent
|
USD | |
CY2021Q4 | CLOQ |
Common Stock Settlement Liability Non Current
CommonStockSettlementLiabilityNonCurrent
|
USD | |
CY2022Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2021Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
USD | |
CY2021Q4 | CLOQ |
Shares To Be Redeemed
SharesToBeRedeemed
|
USD | |
CY2022Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
USD | |
CY2021Q1 | CLOQ |
Loss On Settlement With Officer
LossOnSettlementWithOfficer
|
USD | |
CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
USD | |
CY2022Q1 | us-gaap |
Depreciation
Depreciation
|
USD | |
CY2021Q1 | us-gaap |
Depreciation
Depreciation
|
USD | |
CY2021Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
USD | |
CY2022Q1 | CLOQ |
Loss On Settlement Of Payable
LossOnSettlementOfPayable
|
USD | |
CY2021Q1 | CLOQ |
Gain On Settlement With Officer And Director
GainOnSettlementWithOfficerAndDirector
|
USD | |
CY2021Q1 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
USD | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
USD | |
CY2021Q1 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
USD | |
CY2021Q1 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
USD | |
CY2022Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
USD | |
CY2022Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
USD | |
CY2021Q1 | us-gaap |
Stock Issued1
StockIssued1
|
USD | |
CY2021Q1 | us-gaap |
Liabilities Assumed1
LiabilitiesAssumed1
|
USD | |
CY2022Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
USD | |
CY2022Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
USD | |
CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
USD | |
CY2022Q1 | CLOQ |
Accumulated Impairment Expense
AccumulatedImpairmentExpense
|
USD | |
CY2021Q4 | CLOQ |
Accumulated Impairment Expense
AccumulatedImpairmentExpense
|
USD | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
USD |